Prenetics Global Limited (PRE) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Prenetics Global Limited  (NASDAQ: PRE)
 

Prenetics Global Limited Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRE Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 201.94 % 3.76 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q4 MRQ) - 6.31 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 201.94 % 2.65 % 7.04 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) - 1.15 % 3.51 % 2.08 %
Revenue 5 Year Average Growth - 3.1 % 8.65 % 10.59 %


PRE's Growth Comparisons in IV. Quarter 2025




Impressive surge in Prenetics Global Limited's Revenue in the fourth quarter 2025 by 201.94% from the same quarter a year ago, to 92 millions, appears to be a slow-down from Prenetics Global Limited's growth trends, but competes favorably to the 3.76% growth in the Laboratory Analytical Instruments industry, and 8.07% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Laboratory Analytical Instruments industry, Prenetics Global Limited reported above average market Sales growth.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2025 earnings reports, average yearly sales growth is 10.59%.

PRE Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Goods transferred at a point in time
-
-
Services transferred at a point in time
-
-
Services transferred overtime
-
-
Prevention - genetic testing
-
-
Consumer health - health and wellness solutions
-
-
Consumer health - sports distribution
-
-
Prevention
-
-
Prevention segments
-
-
Consumer Health segments
-
-
Hong Kong
-
-
The United States
-
-
Discontinued operations
-
-
Discontinued operations Hong Kong
-
-
Discontinued operations United Kingdom
-
-
Discontinued operations Taiwan
-
-
Discontinued operations Rest of the world
-
-
Discontinued operations Services transferred at a point in time
-
-
Discontinued operations Diagnostics - sale of precision oncology services
-
-
Discontinued operations Prevention and Diagnostics
-
-
Discontinued operations ACT genomics
-
-
Discontinued operations ACT genomics Hong Kong
-
-
Discontinued operations ACT genomics United Kingdom
-
-
Discontinued operations ACT genomics Taiwan
-
-
Discontinued operations ACT genomics Rest of the world
-
-
Discontinued operations ACT genomics Services transferred at a point in time
-
-
Total
-
-


Growth Rates of PRE's Income in the fourth quarter 2025


PRE Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - -23.53 % 27.58 % 29.95 %
Sequential Operating Income Change (Q4 MRQ) - 172.02 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q4 TTM) - -5.18 % 37.03 % 14.37 %
Sequential Operating Income Growth (Q4 TTM) - -9.95 % 9.74 % 6.96 %
Operating Income 5 Year Avg. Change - -6.57 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 161.63 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - - - 11.13 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - - -25.13 % 16.46 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - 65.14 % -6.43 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change - -16.43 % 0.17 % -28.52 %

PRE Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 159.76 % 16.75 % 21.56 %
Q / Q Net Income Growth (Q4 MRQ) - - -34.6 % 11.12 %
Y / Y Net Income Change (Q4 TTM) - - 32.74 % 16.59 %
Sequential Net Income Change (Q4 TTM) - 67.33 % 7.31 % 6.03 %
Net Income 5 Year Avg. Growth - -16.48 % 9.21 % 22.96 %

PRE's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 170.86 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - - - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth - -21.88 % 0.17 % -28.52 %



PRE EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 168.92 % 16.75 % -28.52 %
Q / Q EPS Net Growth (Q4 MRQ) - - -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - -99.87 %
EPS Net 5 Year Avg. Change - -16.48 % 9.21 % 22.96 %



Prenetics Global Limited reported bottom-line of $ 0.00 in the fourth quarter, compare to $ 0.00 in the same quarter a year ago. Laboratory Analytical Instruments industry grew by 168.92%, while Healthcare sector increased by 16.75%, and overall market improved by 21.56%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2025 financial results, average yearly income per share growth is 22.96%.

PRE Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -38.02 % -10.43 % 2 %
Sequential Free Cash Flow Change (Q4 MRQ) - -4.05 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q4 TTM) - -7.89 % 11.09 % 11.81 %
Sequential Free Cash Flow Change (Q4 TTM) - -5.61 % 1.93 % 2.41 %
Free Cash Flow 5 Year Avg. Change - -2.7 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 532.12 % -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q4 MRQ) - 115.74 % -99.01 % -
Y / Y Net Cash Flow Change (Q4 TTM) - - -23.28 % -
Sequential Net Cash Flow Change (Q4 TTM) - 322.26 % -25.11 % -
Net Cash Flow 5 Year Avg. Change - 16.21 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -79.32 % 1.05 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q4 MRQ) - 24.56 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q4 TTM) -79.32 % -4.05 % 10.57 % 23.88 %
Sequential Capital Expenditures Change (Q4 TTM) -79.32 % 0.18 % 6.56 % 7.02 %
Capital Expenditures 5 Year Avg. Change - 4.39 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.